Deutsche Bank AG bought a new stake in shares of CorVel Corp. (NASDAQ:CRVL – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The firm bought 60,326 shares of the business services provider’s stock, valued at approximately $3,772,000.
Other hedge funds have also made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of CorVel by 0.7% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,961 shares of the business services provider’s stock worth $1,640,000 after buying an additional 115 shares during the last quarter. The Manufacturers Life Insurance Company boosted its stake in CorVel by 0.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,918 shares of the business services provider’s stock valued at $1,636,000 after acquiring an additional 139 shares during the last quarter. MassMutual Private Wealth & Trust FSB grew its holdings in CorVel by 18.9% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,228 shares of the business services provider’s stock worth $77,000 after acquiring an additional 195 shares in the last quarter. Benjamin Edwards Inc. increased its position in shares of CorVel by 6.0% in the 4th quarter. Benjamin Edwards Inc. now owns 3,843 shares of the business services provider’s stock worth $260,000 after purchasing an additional 218 shares during the last quarter. Finally, Rockefeller Capital Management L.P. increased its position in shares of CorVel by 66.9% in the 4th quarter. Rockefeller Capital Management L.P. now owns 574 shares of the business services provider’s stock worth $39,000 after purchasing an additional 230 shares during the last quarter. Institutional investors and hedge funds own 51.36% of the company’s stock.
Insider Buying and Selling at CorVel
In other CorVel news, insider Maxim Shishin sold 2,250 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $60.59, for a total transaction of $136,327.50. Following the completion of the transaction, the insider directly owned 7,050 shares of the company’s stock, valued at $427,159.50. The trade was a 24.19% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Jennifer Yoss sold 2,100 shares of the firm’s stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $70.92, for a total transaction of $148,932.00. Following the completion of the sale, the vice president owned 2,173 shares in the company, valued at $154,109.16. The trade was a 49.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 13,350 shares of company stock valued at $834,080 in the last ninety days. Company insiders own 39.72% of the company’s stock.
CorVel Trading Down 1.5%
CorVel (NASDAQ:CRVL – Get Free Report) last posted its earnings results on Tuesday, August 4th. The business services provider reported $0.63 earnings per share (EPS) for the quarter. CorVel had a return on equity of 29.92% and a net margin of 11.72%.The company had revenue of $259.93 million for the quarter.
Wall Street Analysts Forecast Growth
Several equities analysts have recently commented on CRVL shares. Weiss Ratings raised shares of CorVel from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 16th. Wall Street Zen upgraded CorVel from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has an average rating of “Hold”.
Read Our Latest Stock Analysis on CRVL
About CorVel
CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.
The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).
Further Reading
- Five stocks we like better than CorVel
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding CRVL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CorVel Corp. (NASDAQ:CRVL – Free Report).
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.
